DNMT1 is associated with QDPR downregulation and chemotherapy response in lung adenocarcinoma
Open Access
- 1 September 2026
- journal article
- research article
- Published by Springer Nature in Medical Oncology
- Vol. 43 (10) , 264
Abstract
No abstract availableKeywords
Funding Information
- Kunming Medical University Graduate Innovation Fund (2025S267)
- Science Research Foundation of Yunnan Education Bureau (2025J0186)
- National Natural Science Foundation of China (82160508)
- Yunnan Applied Basic Research Projects (YNWRMY-2019-067)
This publication has 58 references indexed in Scilit:
- Physical Activity, Lifestyle, and Cancer RiskJAMA Oncology, 2026
- Engineered honeysuckle extracellular vesicles loaded in ROS response hydrogel for inhibition of postoperative abdominal adhesionChemical Engineering Journal, 2025
- GMPS inhibits the proliferation and migration of non-small cell lung cancer via the regulation of the DNMT 1/SERPINB2 axisCellular Oncology, 2025
- Epigenetic mechanisms in non-small cell lung cancer therapy and chemoresistanceBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025
- Anti-swelling and ROS-scavenging nanofiber hydrogel to prevent postoperative abdominal adhesionChemical Engineering Journal, 2025
- QDPR deficiency drives immune suppression in pancreatic cancerCell Metabolism, 2024
- Insights into DNMT1 and programmed cell death in diseasesBiomedicine & Pharmacotherapy, 2023
- Mechanisms of resistance to chemotherapy in non-small cell lung cancerArchives of Pharmacal Research, 2021
- DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implicationsCellular Oncology, 2020
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized DataGenetic Epidemiology, 2013